Mercury Bio

Mercury Bio is a proud sponsor of this year's 2024 Partnership Opportunities in Drug Delivery (#PODD2024) conference. Join us in Boston, MA the last week of October as we share fresh research about our unique chimeric yEV? drug delivery technology. Not registered yet? Use the discount code MERCURY20 to save 20%. Learn more at: https://lnkd.in/gQ_wSyBb #DrugDelivery #DrugDevelopment #Biotech #RNA

Mercury Bio is excited to announce the appointment of esteemed biotechnologist and NTx (Nature's Toolbox) co-founder, Alexander Koglin Ph.D., to our Board of Directors! Over his many years as both a company President and CSO, Koglin has successfully navigated the complex pathway of biotech development and deployment. While with NTx he helped raise over $61M USD in capital, coordinated projects with BARDA and DARPA, and established research partnerships with some of the most influential companies in biopharma. As Mercury Bio CEO, Bruce McCormick points out, “Alex [Koglin] understands the complex pathway to the realization of new life-saving technologies. His business experience, penchant for innovation, and passion for ensuring that new therapies will actually reach the people that need them the most, make him an ideal addition to our board.” Learn more about Koglin's new role at Mercury Bio at: https://lnkd.in/gsAvxjKX #BoardAnnouncement #Biopharma #Biotech #Biologics #DrugDelivery

Mercury Bio announced today a multi-partner collaboration to fast-track the research program around our yEV? drug-delivery platform with the support of Los Alamos National Laboratory, the National Center for Genome Resources (NCGR), The University of New Mexico Health Sciences Center, and The University of Texas Medical Branch. We're honored to have such prestigious partners working with us toward a next-generation solution for the safe delivery of proteins, RNA, and drugs to a wide diversity of cellular targets. Read the full press release at: https://lnkd.in/gD4aVdnB #Biotechnology #Bioinformatics #RNA #Pharma #DrugDelivery #Research

Mercury Bio will be at the 4th Annual mRNA-Based Therapeutics Summit in Boston, MA from July 29–31. Our CSO, Richard Sayre PhD, will be delivering a pre-conference focus day presentation about the platform technology we've developed titled: yEVs — Enabling the High-Efficiency Introduction of Diverse Cargos, Including mRNA, Functional Antibodies, & Enzymes, to a Broad Range of Cell & Tissue Types If you're attending the summit be sure to attend this presentation, and then visit us in the days that follow at Booth 12 to discuss the vast potential of our yEV? technology. Can't make it to Boston at the end of July? Contact us and ask to be added to the list of those who'll receive a copy of the presentation following the event. Contact link: https://lnkd.in/g7MtsP9X #mRNA #RNA #DrugDelivery #Antibodies #Biomedical #Biotech

Look who made a surprise visit to Mercury Bio last week. It's Santa Fe Mayor Alan Webber! Mayor Webber is very supportive of Mercury Bio's work, and we were pleased to have an opportunity to show him around our labs. #SantaFe #CityofSantaFe

Mercury Bio is honored and excited to join the Alliance for mRNA Medicines (AMM)! Our Chief Science Officer, Richard Sayre Ph.D., will be taking on a board role with AMM, and we'll be working with some incredible professionals to help advance the profound impact mRNA therapies can offer to the world. #mrna #rnatherapeutics

Mercury Bio is heading to San Francisco! Interested in discussing our yEV drug delivery platform with Richard Sayre, Bruce McCormick, Mike Rice, and Dana Barnard at Biotech Showcase? Schedule a meeting using this link: https://lnkd.in/eJwc63AX

https://lnkd.in/eyhGNgQG

We're thrilled to share that Mercury Bio's Chief Science Officer Richard Sayre, Ph.D., will present at the?2024 Biotech Showcase?in San Francisco?on January 8 at 11:30 am. With over 3,500 attendees from more than 2,300 companies and 35 countries, Biotech Showcase is a premier investor conference committed to building a platform for private and micro-mid-cap biotechnology companies, offering them a unique opportunity to showcase their innovations and engage one-to-one with investors and biopharmaceutical executives. Also attending the conference will be Chief Executive Officer Bruce McCormick, Chairman of the Board Dana Barnard, and Board Member and life sciences veteran Mike Rice. If you'll be attending the event and would like to meet with our team, you can schedule with us directly at https://lnkd.in/eJwc63AX. More information about Biotech Showcase is at https://lnkd.in/ee5di7y. We look forward to seeing you there! #BiotechShowcase #Biopharma #Biotech #Biologics #DrugDelivery